Autonomix Capex To Revenue from 2010 to 2024
| AMIX Stock | 3.87 0.10 2.52% |
Capex To Revenue | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Autonomix Medical, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Autonomix Medical,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 77 K, Interest Expense of 79.2 K or Selling General Administrative of 5.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.04. Autonomix financial statements analysis is a perfect complement when working with Autonomix Medical, Valuation or Volatility modules.
Autonomix |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.